TMPRSS2 and prostate cancer: This is highlighted by the finding of Mosquera et al (2009) that Caucasian populations were less likely to have the TMPRSS2–ERG fusion and this could explain the 22.6% prevalence rate observed by Setlur et al (2008) in a Swedish cohort of 455 prostate cancer cases.